Since my earlier piece this June on Agree Realty, the total return performance has landed at close to 25%. Read why I remain ...

Jane Fraser's strategic overhaul is making significant progress for Citigroup, aiming for 11%-12% RoTCE by 2026. Read why I ...

The PAVE ETF has outperformed in recent years due to a favorable macroeconomic backdrop. Click here to find out the reasons ...

Discover why Deutsche Bank is a strong investment option with potential for a 30% return in the next three years, supported ...

Discover why the HYDB fund is a strong investment opportunity with its focus on high-yield corporate bonds and consistent ...

The bloom may be off the rose for obesity drugs as reports of side effects for high doses of GLP-1 drugs. GLP-1s were ...

Despite underperformance, B2Gold's diverse portfolio and recent agreements in Mali mitigate risks. Read why I think BTG stock ...

PAVE ETF offers exposure to U.S. infrastructure companies but may not be a compelling investment due to election uncertainty ...

The market is split on the Fed cutting by a quarter or half point. FedEx is the big earnings report this week. Disney and ...

The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a high yield with leverage, strong performance, and potential for ...

Discover why Nu Holdings is a compelling investment opportunity with its hyper-growth, attractive unit economics, and ...

Organigram's (OGI) stock surged 22% since my last analysis, outperforming cannabis market, yet remains a buy due to its ...